Segment disclosures

Company overview

파인메딕스

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 17 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-304031209843 KRW20260813Open filing evidence
2026-01-01 – 2026-06-306263008055 KRW20260813Open filing evidence
2026-01-01 – 2026-03-312231798212 KRW20260514Open filing evidence
2025-01-01 – 2025-12-319522704304 KRW20260626Open filing evidence
2025-07-01 – 2025-09-302197243638 KRW20251114Open filing evidence
2025-01-01 – 2025-09-306555997260 KRW20251114Open filing evidence
2025-04-01 – 2025-06-302460074932 KRW20260813Open filing evidence
2025-01-01 – 2025-06-304358753622 KRW20260813Open filing evidence
2025-01-01 – 2025-03-311898678690 KRW20260514Open filing evidence
2024-01-01 – 2024-12-319960360985 KRW20260626Open filing evidence
2024-07-01 – 2024-09-302310316034 KRW20251114Open filing evidence
2024-01-01 – 2024-09-306032844769 KRW20251114Open filing evidence
2024-04-01 – 2024-06-301949425082 KRW20250814Open filing evidence
2024-01-01 – 2024-06-303722528735 KRW20250814Open filing evidence
2024-01-01 – 2024-03-311773103653 KRW20250514Open filing evidence
2023-01-01 – 2023-12-3110154094544 KRW20260626Open filing evidence
2022-01-01 – 2022-12-318142079174 KRW20250318Open filing evidence